The association between the use of proton pump inhibitors and the risk of hypomagnesemia: a systematic review and meta-analysis - PubMed (original) (raw)

Review

The association between the use of proton pump inhibitors and the risk of hypomagnesemia: a systematic review and meta-analysis

Chan Hyuk Park et al. PLoS One. 2014.

Abstract

Background: Although many case reports have described patients with proton pump inhibitor (PPI)-induced hypomagnesemia, the impact of PPI use on hypomagnesemia has not been fully clarified through comparative studies. We aimed to evaluate the association between the use of PPI and the risk of developing hypomagnesemia by conducting a systematic review with meta-analysis.

Methods: We conducted a systematic search of MEDLINE, EMBASE, and the Cochrane Library using the primary keywords "proton pump," "dexlansoprazole," "esomeprazole," "ilaprazole," "lansoprazole," "omeprazole," "pantoprazole," "rabeprazole," "hypomagnesemia," "hypomagnesaemia," and "magnesium." Studies were included if they evaluated the association between PPI use and hypomagnesemia and reported relative risks or odds ratios or provided data for their estimation. Pooled odds ratios with 95% confidence intervals were calculated using the random effects model. Statistical heterogeneity was assessed with Cochran's Q test and I2 statistics.

Results: Nine studies including 115,455 patients were analyzed. The median Newcastle-Ottawa quality score for the included studies was seven (range, 6-9). Among patients taking PPIs, the median proportion of patients with hypomagnesemia was 27.1% (range, 11.3-55.2%) across all included studies. Among patients not taking PPIs, the median proportion of patients with hypomagnesemia was 18.4% (range, 4.3-52.7%). On meta-analysis, pooled odds ratio for PPI use was found to be 1.775 (95% confidence interval 1.077-2.924). Significant heterogeneity was identified using Cochran's Q test (df = 7, P<0.001, I2 = 98.0%).

Conclusions: PPI use may increase the risk of hypomagnesemia. However, significant heterogeneity among the included studies prevented us from reaching a definitive conclusion.

PubMed Disclaimer

Conflict of interest statement

Competing Interests: The authors have declared that no competing interests exist.

Figures

Figure 1

Figure 1. Flow diagram of studies included in the meta-analysis.

PPI, proton pump inhibitor.

Figure 2

Figure 2. Forest plots for risk of hypomagnesemia.

PPI, proton pump inhibitor; CI, confidence interval.

Figure 3

Figure 3. Subgroup analysis for studies which included only hospitalized patients.

PPI, proton pump inhibitor; CI, confidence interval.

Figure 4

Figure 4. Subgroup analysis according to the cut-off value of serum magnesium levels.

(A) Subgroup analysis for studies based on the 1.7 mg/dL of cut-off value. (B) Subgroup analysis for studies based on the 1.8 mg/dL of cut-off value. PPI, proton pump inhibitor; CI, confidence interval.

Comment in

Similar articles

Cited by

References

    1. Lacy BE, Talley NJ, Locke GR, Bouras EP, DiBaise JK, et al. (2012) Review article: current treatment options and management of functional dyspepsia. Alimentary pharmacology & therapeutics 36: 3–15. - PMC - PubMed
    1. Yeomans ND, Tulassay Z, Juhasz L, RÃcz I, Howard JM, et al. (1998) A comparison of omeprazole with ranitidine for ulcers associated with nonsteroidal antiinflammatory drugs. Acid Suppression Trial: Ranitidine versus Omeprazole for NSAID-associated Ulcer Treatment (ASTRONAUT) Study Group. The New England journal of medicine 338: 719–726. - PubMed
    1. Hawkey CJ, Karrasch JA, Szczepanski L, Walker DG, Barkun A, et al. (1998) Omeprazole compared with misoprostol for ulcers associated with nonsteroidal antiinflammatory drugs. Omeprazole versus Misoprostol for NSAID-induced Ulcer Management (OMNIUM) Study Group. The New England journal of medicine 338: 727–734. - PubMed
    1. Kahrilas PJ, Shaheen NJ, Vaezi MF, Hiltz SW, Black E, et al. (2008) American Gastroenterological Association Medical Position Statement on the management of gastroesophageal reflux disease. Gastroenterology 135: 1383–1391 1391: e1381. - PubMed
    1. Xiao Y, Peng S, Tao J, Wang A, Lin J, et al. (2010) Prevalence and symptom pattern of pathologic esophageal acid reflux in patients with functional dyspepsia based on the Rome III criteria. The American journal of gastroenterology 105: 2626–2631. - PubMed

Publication types

MeSH terms

Substances

Grants and funding

The authors have no funding or support to report.

LinkOut - more resources